title: Hydrodynamic-based delivery of PTP1B shRNA reduces plasma glucose levels in diabetic mice.
abstract: Protein tyrosine phosphatase 1B (PTP1B) is a negative regulator of insulin signaling which is overexpressed in the liver of diabetic animals. The aims of this study were to generate liver-specific PTP1B knockout mice using a PTP1B‑short hairpin RNA (shRNA) plasmid and to investigate the effect of PTP1B inhibition on plasma glucose levels in streptozotocin-induced diabetic mice. We first validated the hydrodynamic tail vein injection in mice using a vector carrying the luciferase gene. Expression of the PTP1B gene was quantified by real-time PCR. The level of phosphorylated Akt was examined by western blot analysis. The injection of the plasmid containing firefly luciferase revealed that the highest transfer of the vector into the liver was obtained 24 h after the injection of 20 µg plasmid. The injection of PTP1B-shRNA, but not the scrambled shRNA plasmid, resulted in a reduction in PTP1B expression levels by up to 84% in the liver of the diabetic mice. Plasma glucose levels following the injection of PTP1B-shRNA remained significantly lower in the diabetic mice for 5 days. In addition, mice receiving PTP1B-shRNA in the basal and insulin-stimulated states had higher levels of Akt phosphorylation in the liver cells compared with mice that were injected with the scrambled sequence (35 and 60%, respectively; p<0.01). Furthermore, PTP1B overexpression was observed in the muscle, liver, adipose, heart and kidney tissues of the diabetic mice. The data from this study demonstrate that PTP1B inhibition may be a promising approach for lowering plasma glucose levels in diabetic patients. However, further studies using non-viral carriers are required to deliver the plasmid safely into the liver.
authors.affiliation: Department of Biochemistry, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
authors.forename: Sanaz
authors.initials: S
authors.lastname: Vakili
authors.forename: Shadi Sadat Seyyed
authors.initials: SS
authors.lastname: Ebrahimi
authors.forename: Asie
authors.initials: A
authors.lastname: Sadeghi
authors.forename: Sattar
authors.initials: S
authors.lastname: Gorgani-Firuzjaee
authors.forename: Maani
authors.initials: M
authors.lastname: Beigy
authors.forename: Parvin
authors.initials: P
authors.lastname: Pasalar
authors.forename: Reza
authors.initials: R
authors.lastname: Meshkani
mesh_terms: D000818:Animals; D001786:Blood Glucose; D003921:Diabetes Mellitus, Experimental / Q000235:genetics* / Q000378:metabolism*; D015870:Gene Expression; D055785:Gene Knockdown Techniques; D018014:Gene Transfer Techniques; D007275:Injections, Intravenous; D007328:Insulin / Q000378:metabolism; D008055:Lipids / Q000097:blood; D008099:Liver / Q000378:metabolism; D008297:Male; D009928:Organ Specificity / Q000235:genetics; D054562:Protein Tyrosine Phosphatase, Non-Receptor Type 1 / Q000235:genetics* / Q000378:metabolism; D034741:RNA, Small Interfering / Q000008:administration & dosage / Q000235:genetics*; D015398:Signal Transduction
chemical_list: D001786:Blood Glucose; D007328:Insulin; D008055:Lipids; D034741:RNA, Small Interfering; D054562:Protein Tyrosine Phosphatase, Non-Receptor Type 1